Sakae Tanaka

70PUBLICATIONS
134CO-AUTHORS
Tumour immunologyGene expression (incl. microarray and other genome-wide approaches)AllergyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (70)

|Sep 08, 2026
Impact of burosumab on kinetics of intact FGF23 values after the removal of a causative tumor in a patient with tumor-induced osteomalacia.

|Sep 07, 2026
PDGFRA amplification could be a poor prognostic factor of advanced undifferentiated pleomorphic sarcoma in a comprehensive genomic profiling cohort.

|Aug 19, 2026
Safety of intravenous and subcutaneous belimumab in Japanese patients with systemic lupus erythematosus: Final analysis of data from an all-case post-marketing surveillance study.

|Jul 22, 2026
Osteoarthritis risk associated with denosumab in adults with osteoporosis: A target trial emulation.

|Jun 29, 2026
Incidence and Radiographic Progression of Rheumatoid Arthritis in Anti-Citrullinated Protein Antibody-Positive Individuals: A Six-Year Population- Based Cohort Study.

|May 07, 2026
Oral bisphosphonates and risk of incident osteoarthritis in individuals with osteoporosis: a target trial emulation.

Pageof 12

Frequent Collaborators

17 joint publications

Takumi Matsumoto

7 joint publications

Taku Saito

6 joint publications

Yasunori Omata

5 joint publications

Hiroshi Kobayashi